A Case of Type 2 Diabetes Mellitus with Lung Cancer Suffered from Euglycemic Diabetic Ketosis Accompanied by Adrenal Insufficiency after Immune Checkpoint Inhibitors
A 74-year-old patient with type 2 diabetes mellitus received basal-bolus insulin, insulin secretagogues, and sodium glucose transporter 2 (SGLT2) inhibitors. After immune checkpoint inhibitor treatment for lung cancer, he suffered from depressed consciousness with a urinary ketone body (3+). When al...
Saved in:
| Main Authors: | Saeko Shibasaki, Chisei Noda, Akihisa Imagawa, Sadaki Sakane |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Case Reports in Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2024/9982174 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ketosis-Onset Diabetes and Ketosis-Prone Diabetes: Same or Not?
by: Beiyan Liu, et al.
Published: (2013-01-01) -
Adrenal insufficiency induced by immune checkpoint inhibitors anticancer therapy
by: Paulina Ramaneckaite, et al.
Published: (2025-01-01) -
Euglycemic diabetic ketoacidosis in a pregnant woman
by: Gufran Algaly, et al.
Published: (2023-12-01) -
Ketosis-prone type 2 diabetes mellitus (review of the literature)
by: Natalya Alexandrovna Molitvoslovova,, et al.
Published: (2009-09-01) -
Chemotherapy-Induced Regression of an Adrenocorticotropin-Secreting Pituitary Carcinoma Accompanied by Secondary Adrenal Insufficiency
by: Robert Frank Cornell, et al.
Published: (2013-01-01)